Avidity Partners Management LP lowered its stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 68.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 235,000 shares of the company’s stock after selling 504,100 shares during the quarter. Avidity Partners Management LP […]
Avidity Partners Management LP lessened its position in shares of argenx SE (NASDAQ:ARGX – Free Report) by 61.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 31,000 shares of the company’s stock after selling 49,600 shares during the period. Avidity Partners Management LP’s holdings in argenx were worth $11,793,000 at the end […]
Avidity Partners Management LP bought a new position in Neurogene Inc. (NASDAQ:NGNE – Free Report) during the 4th quarter, Holdings Channel reports. The firm bought 466,243 shares of the company’s stock, valued at approximately $9,036,000. Avidity Partners Management LP owned about 0.20% of Neurogene as of its most recent SEC filing. Separately, BML Capital Management […]
Avidity Partners Management LP bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 99,000 shares of the medical research company’s stock, valued at approximately $13,764,000. Several other large investors also […]
Avidity Partners Management LP cut its holdings in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 37.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 827,010 shares of the company’s stock after selling 495,990 shares during the period. Avidity Partners Management […]